Position in NAMS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$330,779,298
+$18,397,692 QoQ
Shares Held
9,883,524
0.0% QoQ
Ownership
8.27%
of shares outstanding
% of Portfolio
2.91%
of 13F equity value
Holder Rank
#4
of 198 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RA CAPITAL MANAGEMENT, L.P. holds $11,082,969,028 across 75 Biotechnology names. NAMS ranks #8 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
10,281,496 | $2,742,280,613 | |
| 2 | PBLS |
Parabilis Medicines, Inc.
|
28,933,371 | $791,906,364 | |
| 3 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
6,666,837 | $740,218,912 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
11,474,599 | $667,018,439 | |
| 5 | SION |
Sionna Therapeutics, Inc.
|
9,905,045 | $435,722,929 | |
| 6 | TYRA |
Tyra Biosciences, Inc.
|
12,198,625 | $389,624,082 | |
| 7 | EWTX |
Edgewise Therapeutics, Inc.
|
8,392,730 | $340,996,619 | |
| 8 | NAMS |
NewAmsterdam Pharma Co N.V.
This page
|
9,883,524 | $330,779,298 |
All Filings in NAMS
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 NAMSW | $7,123,326 | 333,333 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $323,655,972 | 9,550,191 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 NAMSW | $6,679,993 | 333,333 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $305,701,613 | 9,550,191 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 NAMSW | $7,666,659 | 333,333 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $335,020,700 | 9,550,191 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 NAMSW | $5,703,327 | 333,333 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $288,351,396 | 10,138,938 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 NAMSW | $2,666,664 | 333,333 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $183,616,167 | 10,138,938 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 NAMSW | $2,996,663 | 333,333 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $207,544,060 | 10,138,938 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 NAMSW | $4,749,995 | 333,333 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $227,316,500 | 8,845,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 NAMSW | $2,333,331 | 333,333 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $133,862,400 | 8,064,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 NAMSW | $2,906,663 | 333,333 | Shares | Sole | 2024-08-14 | |
| 2024-06-30 | $154,909,440 | 8,064,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 NAMSW | $3,679,996 | 333,333 | Shares | Sole | 2024-05-15 | |
| 2024-03-31 | $185,983,600 | 7,864,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 NAMSW | $1,043,332 | 333,333 | Shares | Sole | 2024-02-14 | |
| 2023-12-31 | $87,840,880 | 7,864,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 NAMSW | $633,332 | 333,333 | Shares | Sole | 2023-11-14 | |
| 2023-09-30 | $83,250,000 | 9,000,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 NAMSW | $696,665 | 333,333 | Shares | Sole | 2023-08-14 | |
| 2023-06-30 | $107,010,000 | 9,000,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 NAMSW | $613,332 | 333,333 | Shares | Sole | 2023-05-15 | |
| 2023-03-31 | $53,040,000 | 4,000,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 NAMSW | $289,333 | 333,333 | Shares | Sole | 2023-02-14 | |
| 2022-12-31 | $43,600,000 | 4,000,000 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||